Live Breaking News & Updates on Advance Cannquit N

Stay updated with breaking news from Advance cannquit n. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Incannex Healthcare June 2023 Quarterly Activities Report and Appendix 4C Cash Flow Statement

28.07.2023 - MELBOURNE, Australia, July 28, 2023 (GLOBE NEWSWIRE) - Clinical stage pharmaceutical development company, Incannex Healthcare Limited (ASX: IHL) (NASDAQ: IXHL), (‘Incannex’ or the ‘Company’), is pleased to provide its quarterly activities report . ....

South Australia , United States , New Zealand , Joel Latham , Redomiciling Incannex , Peter Widdows , April Incannex , Drug Administration , Early Phase Clinical Research , Incannex Healthcare , Clinical Research , Iv Clinical Research , Quest Pharmaceutical Services , Clarion Clinics Group Pty Ltd , Human Research Ethics Committee , Clarion Clinics Group , European Union Medicines Agency , Corporate Governance Council Principles , Disclosure Committee , Apirx Pharmaceuticals , Incannex Healthcare Inc , Obstructive Sleep Apnoea , Obstructive Sleep , Investigational New Drug , Trial Investigating , Managing Director ,

Date: April 14, 2023 Public Announcement (NASDAQ: IXHL) (ASX: IHL) - Form 6-K

Date: April 14, 2023

Public Announcement

Incannex Appoints QPS to Advance. | April 14, 2023 ....

United States , Joel Latham , Marcus Meinardi , Apirx Pharmaceuticals , European Union Medicines Agency , Incannex Healthcare Ltd Nasdaq , Centre For Disease Control , Edison Group , Australian Stock Exchange , Iv Clinical Research , Early Phase Clinical Research , Incannex Healthcare , Market Research , Quest Pharmaceutical Services , Incannex Healthcare Limited , Drug Administration , Advance Cannquit N , Healthcare Ltd , Translational Medicine , European Union , European Medicines Agency , Managing Director , Healthcare Limited , Rialto South Tower , Disease Control , Alcohol Dependence ,